CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...

Bearish flow noted in CVS Health (CVS) with 13,937 puts trading, or 2x expected. Most active are Mar-25 60 puts and Feb-25 63 puts, with total ...

A Missouri district court judge said stopping the FTC’s suit against Caremark, Express Scripts and Optum Rx would be “against ...

CVS Health has named Ed DeVaney president of the company's CVS Caremark pharmacy benefits manager business, CVS announced this week. DeVaney ascends to the top post after having been named interim ...

Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

President Donald Trump’s executive order to expand access to in vitro fertilization doesn’t immediately change any policy, ...

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.